Markers of inflammation as determinants of mortality in intensive care unit patients
dc.contributor.author | Kuvandik, Guven | |
dc.contributor.author | Ucar, Edip | |
dc.contributor.author | Borazan, Ali | |
dc.contributor.author | Aydemir, Selim | |
dc.contributor.author | Ilikhan, Sevil | |
dc.contributor.author | Sekitmez, Nedred | |
dc.contributor.author | Duru, Mehmet | |
dc.date.accessioned | 2024-09-18T20:28:08Z | |
dc.date.available | 2024-09-18T20:28:08Z | |
dc.date.issued | 2007 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | In this study, the investigators explored the relationship between mortality rate and serum levels of C-reactive protein (CRP), erythrocyte sedimentation ratio (ESR), albumin, and hemoglobin, leukocyte, and platelet counts of patients at the time of first admission to the intensive care unit (ICU). A total of 123 patients were admitted to 2 different ICUs. In the emergency departments, serum levels of CRP, ESR, and albumin and hematologic parameters of 81 patients who died and were 42 patients who survived were compared. Student t test and the chi(2) test were used for statistical analyses. Mean CRP and ESR levels and leukocyte counts were higher in nonsurvivor than in survivor groups (P<.001 for all). Additionally, serum CRP and ESR elevations and leukocyte counts were determined to be individually related to mortality (P<.001, P<.05, and P<.05, respectively). The investigators concluded that initial serum levels of CRP and ESR and leukocyte counts can be used as determinants of mortality in ICU patients. | en_US |
dc.identifier.doi | 10.1007/BF02877714 | |
dc.identifier.endpage | 1084 | en_US |
dc.identifier.issn | 0741-238X | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 18029335 | en_US |
dc.identifier.scopus | 2-s2.0-37249026186 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 1078 | en_US |
dc.identifier.uri | https://doi.org/10.1007/BF02877714 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/10757 | |
dc.identifier.volume | 24 | en_US |
dc.identifier.wos | WOS:000251636700017 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Advances in Therapy | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | intensive care | en_US |
dc.subject | mortality rate | en_US |
dc.subject | C-reactive protein | en_US |
dc.subject | erythrocyte sedimentation rate | en_US |
dc.subject | hemoglobin | en_US |
dc.subject | leukocyte count | en_US |
dc.subject | platelet count | en_US |
dc.title | Markers of inflammation as determinants of mortality in intensive care unit patients | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1